Initial Statement of Beneficial Ownership (3)
January 29 2013 - 1:33PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Belldegrun Arie
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/25/2013
|
3. Issuer Name
and
Ticker or Trading Symbol
Arno Therapeutics, Inc [ARNI]
|
(Last)
(First)
(Middle)
C/O ARNO THERAPEUTICS, INC., 200 ROUTE 31 NORTH, SUITE 104
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
FLEMINGTON, NJ 08822
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
24922
|
D
|
|
Common Stock
|
317155
|
I
|
Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust
(3)
|
Common Stock
|
127619
|
I
|
Belldegrun Family Trust
(4)
|
Common Stock
|
127619
|
I
|
MDRB Partnership, L.P.
(5)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option (right to buy)
|
(1)
|
3/31/2018
|
Common Stock
|
199377
|
$2.42
|
D
|
|
Stock Option (right to buy)
|
(1)
|
9/29/2019
|
Common Stock
|
10000
|
$1.00
|
D
|
|
Stock Option (right to buy)
|
(1)
|
9/9/2020
|
Common Stock
|
300000
|
$1.00
|
D
|
|
Stock Option (right to buy)
|
(2)
|
11/5/2020
|
Common Stock
|
10000
|
$1.00
|
D
|
|
Class A Warrants (right to buy)
|
9/9/2010
|
3/9/2013
|
Common Stock
|
20000
|
$.5268
|
I
|
Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust
(3)
|
Class B Warrants (right to buy)
|
9/9/2010
|
9/9/2015
|
Common Stock
|
105000
|
$.5649
|
I
|
Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust
(3)
|
8% Senior Convertible Debentures
|
11/26/2012
|
11/26/2015
|
Common Stock
|
1000000
|
$.30
|
I
|
Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust
(6)
|
Series A Warrants (right to buy)
|
11/26/2012
|
11/26/2017
|
Common Stock
|
1000000
|
$.50
|
I
|
Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust
(6)
|
Series B Warrants
|
11/26/2012
|
5/26/2014
|
Common Stock
|
1000000
|
$.30
|
I
|
Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust
(6)
|
Class A Warrants (right to buy)
|
9/9/2010
|
3/9/2013
|
Common Stock
|
10000
|
$.5268
|
I
|
Belldegrun Family Trust
(4)
|
Class B Warrants (right to buy)
|
9/9/2010
|
9/9/2015
|
Common Stock
|
52500
|
$.5649
|
I
|
Belldegrun Family Trust
(4)
|
8% Senior Convertible Debentures
|
11/26/2012
|
11/26/2015
|
Common Stock
|
1166667
|
$.30
|
I
|
Belldegrun Family Trust
(4)
|
Series A Warrants (right to buy)
|
11/26/2012
|
11/26/2017
|
Common Stock
|
1166667
|
$.50
|
I
|
Belldegrun Family Trust
(4)
|
Series B Warrants (right to buy)
|
11/26/2012
|
5/26/2014
|
Common Stock
|
1166667
|
$.30
|
I
|
Belldegrun Family Trust
(4)
|
Class A Warrants (right to buy)
|
9/9/2010
|
3/9/2013
|
Common Stock
|
10000
|
$.5268
|
I
|
MDRB Partnership, L.P.
(5)
|
Class B Warrants (right to buy)
|
9/9/2010
|
9/9/2015
|
Common Stock
|
52500
|
$.5649
|
I
|
MDRB Partnership, L.P.
(5)
|
8% Senior Convertible Debentures
|
11/26/2012
|
11/26/2015
|
Common Stock
|
500000
|
$.30
|
I
|
MDRB Partnership, L.P.
(5)
|
Series A Warrants (right to buy)
|
11/26/2012
|
11/26/2017
|
Common Stock
|
500000
|
$.50
|
I
|
MDRB Partnership, L.P.
(5)
|
Series B Warrants (right to buy)
|
11/26/2012
|
5/26/2014
|
Common Stock
|
500000
|
$.30
|
I
|
MDRB Partnership, L.P.
(5)
|
8% Senior Convertible Debentures
|
11/26/2012
|
11/26/2015
|
Common Stock
|
666667
|
$.30
|
I
|
Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan
(7)
|
Series A Warrants (right to buy)
|
11/26/2012
|
11/26/2017
|
Common Stock
|
666667
|
$.50
|
I
|
Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan
(7)
|
Series B Warrants (right to buy)
|
11/26/2012
|
5/26/2014
|
Common Stock
|
666667
|
$.30
|
I
|
Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan
(7)
|
Explanation of Responses:
|
(
1)
|
Currently exercisable.
|
(
2)
|
Vests in three equal annual installments commencing 11/5/11.
|
(
3)
|
Although the Reporting Person is not a trustee of the BTL Trust, the Reporting Person is a beneficiary of the BTL Trust, and as such may be deemed to be the beneficial owner of the securities owned by the BTL Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
|
(
4)
|
The Reporting Person is the trustee of the family trust that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
|
(
5)
|
The Reporting Person is the managing partner of the limited partnership that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
|
(
6)
|
Although the Reporting Person is not a trustee of the Tampere Trust, the Reporting Person is a beneficiary of the Tampere Trust, and as such may be deemed to be the beneficial owner of the securities owned by the Tampere Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
|
(
7)
|
The Reporting Person is the trustee of the profit sharing plan that owns the securities.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Belldegrun Arie
C/O ARNO THERAPEUTICS, INC.
200 ROUTE 31 NORTH, SUITE 104
FLEMINGTON, NJ 08822
|
X
|
|
|
|
Signatures
|
/s/ Arie S. Belldegrun, M.D.
|
|
1/25/2013
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Arno Therapeutics (CE) (USOTC:ARNI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Arno Therapeutics (CE) (USOTC:ARNI)
Historical Stock Chart
From Jul 2023 to Jul 2024